Table 1 AHR staining and clinicopathological characteristics of hepatocellular carcinoma patients
From: AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma
Variable | Number | AHR high staining | AHR low staining | P value |
|---|---|---|---|---|
Age No. (%) | ||||
>50 | 24(55.8) | 13(65.0) | 12(52.2) | 0.3951 |
≤50 | 19(44.2) | 7(36.0) | 11(47.8) |  |
Gender No. (%) | ||||
Male | 31(72.1) | 14(70.0) | 17(73.9) | 0.7754 |
Female | 12(27.9) | 6(30.0) | 6(26.1) | Â |
Edmondson-Steiner grade No. (%) | ||||
I | 1(2.3) | 0(0) | 1(4.3) | 0.3454 |
II/III | 42(97.7) | 20(100.0) | 22(95.7) | Â |
HBsAg No. (%) | ||||
(+) | 30(70.0) | 18(90.0) | 12(57.1) | 0.0533 |
(-) | 13(30.0) | 2(10.0) | 9(42.9) | Â |
AFM1 in urine No. (%) | ||||
Y | 10(23.2) | 7(35.0) | 3(13.0) | 0.089 |
N.D. | 33(76.7) | 13(65.0) | 20(87.0) | Â |
Cirrhosis No. (%) | ||||
Y | 26(60.5%) | 10(50.0) | 16(76.2) | 0.0818 |
N | 17(39.5%) | 10(50.0) | 5(23.8) | Â |
